Resveratrol regulates neuro-inflammation and induces adaptive immunity in Alzheimer’s disease - Moussa, Charbel; Hebron, Michaeline; Huang, Xu; Ahn, Jaeil; Rissman, Robert A.; Aisen, Paul S.; Turner, R. Scott (Journal of neuroinflammation, 2017)
Keywords: Activities of Daily Living; Adaptive Immunity - drug effects; Alzheimer Disease - complications; Alzheimer Disease - drug therapy; Alzheimer Disease - metabolism; Alzheimer Disease - psychology; Alzheimer's disease; Amyloid beta-Peptides - blood; Amyloid beta-Peptides - cerebrospinal fluid; Analysis; Anti-Inflammatory Agents, Non-Steroidal - pharmacology; Anti-Inflammatory Agents, Non-Steroidal - therapeutic use; Care and treatment; Chemokine CCL5 - metabolism; Cognition Disorders - drug therapy; Cognition Disorders - etiology; Cytokines - metabolism; Dosage and administration; Double-Blind Method; Encephalitis - drug therapy; Encephalitis - etiology; Female; Fibroblast Growth Factor 2 - cerebrospinal fluid; Fibroblast growth factors; Follow-Up Studies; Humans; Inflammation; Male; Matrix Metalloproteinase 9 - cerebrospinal fluid; Mental Status Schedule; Peptide Fragments - cerebrospinal fluid; Resveratrol; Stilbenes - pharmacology; Stilbenes - therapeutic use; tau Proteins - blood; tau Proteins - cerebrospinal fluid; United States; Interleukin-4; Macrophage-derived chemokine (MDC); Matrix metalloproteinase-(MMP)-9; Alzheimer; Resveratrol